Phase 2 Cytokine Release Syndrome Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
Cytokine Release Syndrome
CytoAgents, Inc.54 enrolled6 locationsNCT05905328
Recruiting
Phase 2
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
MyelomaCRS - Cytokine Release Syndrome
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT07106671